首页 » D2.0R BioVector®小鼠乳腺癌休眠细胞系 / D2.0R Mouse Mammary Carcinoma Dormancy Cell Line

D2.0R BioVector®小鼠乳腺癌休眠细胞系 / D2.0R Mouse Mammary Carcinoma Dormancy Cell Line

  • 价  格:¥99850
  • 货  号:BioVector®-D2.0R
  • 产  地:北京
点击询问我要采购
 竭诚为您服务!
BioVector NTCC典型培养物保藏中心
联系人:Dr.Xu, Biovector NTCC Inc.

电话:400-800-2947 工作微信:1843439339 (QQ同号)

邮件:Biovector@163.com

手机:18901268599

地址:北京

已注册
 

BioVector® D2.0R 小鼠乳腺癌休眠细胞系 / D2.0R Mouse Mammary Carcinoma Dormancy Cell Line

通用定义 / General Definition:

BioVector® D2.0R 是一种源自 BALB/c 小鼠自发性乳腺肿瘤的永久性细胞系。该细胞系在生物医学研究中具有独特地位,因为它在体外(In Vitro)能够正常增殖,但在植入体内(In Vivo)后会进入长时间的细胞周期停滞或休眠状态。这使其成为研究癌症远端转移、免疫逃逸及休眠唤醒机制的核心工具。

BioVector® D2.0R is a permanent cell line derived from a spontaneous mammary tumor in BALB/c mice. It holds a unique position in biomedical research due to its ability to proliferate normally In Vitro while entering a prolonged state of cell cycle arrest or dormancy upon In Vivo implantation. This makes it a pivotal tool for investigating cancer metastasis, immune evasion, and the mechanisms of dormancy awakening.


BioVector® D2.0R 细胞系技术说明书 (Cell Line Datasheet)

中文版说明书

1. 产品基本信息

  • 产品名称: BioVector® D2.0R 小鼠乳腺癌休眠细胞

  • 细胞来源: 小鼠 (BALB/c)

  • 组织来源: 乳腺

  • 生长特性: 贴壁生长

  • 细胞形态: 上皮细胞样

2. 培养条件

  • 基础培养基: BioVector® DMEM 培养基

  • 血清添加: 10% BioVector® 胎牛血清 (FBS)

  • 培养环境: 37°C,5% $CO_2$,饱和湿度

3. 细胞应用

  • 肿瘤细胞休眠与唤醒机制研究。

  • 抗肿瘤药物筛选(特别是针对非增殖期微小残留病灶)。

  • 肿瘤微环境与转移前生态位 (Pre-metastatic Niche) 研究。

4. 注意事项

  • 表型转换: BioVector® D2.0R 细胞在体外培养时保持增殖,但在注入小鼠体内后表现出明显的休眠表型。

  • 传代建议: 建议在细胞达到 80%-90% 汇合度时进行传代。


English Datasheet

1. General Product Information

  • Product Name: BioVector® D2.0R Mouse Mammary Carcinoma Dormancy Cell Line

  • Organism: Mouse (BALB/c)

  • Tissue Source: Mammary Gland

  • Growth Properties: Adherent

  • Morphology: Epithelial-like

2. Culture Conditions

  • Basal Medium: BioVector® DMEM Medium

  • Serum Supplement: 10% BioVector® Fetal Bovine Serum (FBS)

  • Incubation: 37°C, 5% $CO_2$, Saturated Humidity

3. Applications

  • Mechanistic studies of tumor cell dormancy and reactivation.

  • Anti-tumor drug screening (targeting non-proliferative Minimal Residual Disease).

  • Research on tumor microenvironment and the pre-metastatic niche.

4. Key Usage Notes

  • Phenotypic Switch: While BioVector® D2.0R cells proliferate actively in vitro, they exhibit a distinct dormant phenotype when injected in vivo.

  • Subculture: It is recommended to subculture when the cell density reaches 80%-90% confluence.


Note: Always handle BioVector® D2.0R cells using standard Biosafety Level 2 (BSL-2) protocols. Consistent use of BioVector® DMEM Medium and BioVector® Fetal Bovine Serum is essential for maintaining phenotypic stability.


BioVector NTCC质粒载体菌株细胞蛋白抗体基因保藏中心

E-mail: BioVector@163.com

http://www.biovector.net


您正在向 biovector.net  发送关于产品 D2.0R BioVector®小鼠乳腺癌休眠细胞系 / D2.0R Mouse Mammary Carcinoma Dormancy Cell Line 的询问

点击“立即发送”后,我们将在1个工作日内与您取得联系。